Jia-Chuan Shen

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Hepatocellular carcinoma (HCC) and other forms of metastatic liver cancer (MLC) have poor outcomes due to the limited treatment options. Surgery, radiotherapy and chemotherapy have a limited success. Thus, there is an urgent need for novel therapies for patients with advanced HCC and MLC. The response and toxicity profile of a novel biological anticancer(More)
  • 1